10-Alkyl- and 10-aminoalkyl-2,2'-bis(trifluoromethyl)-3,10'-biphenothiazines.
D000284:Administration, Oral; D000818:Animals; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000138:chemical synthesis* / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004597:Electroshock; D006801:Humans; D006845:Hydrocarbons, Fluorinated / Q000008:administration & dosage / Q000138:chemical synthesis / Q000494:pharmacology; D007274:Injections, Intraperitoneal; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D013058:Mass Spectrometry; D008722:Methods; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D010433:Pentylenetetrazole / Q000037:antagonists & inhibitors; D051381:Rats; D012110:Reserpine / Q000037:antagonists & inhibitors; D013239:Stereotyped Behavior / Q000187:drug effects; D013331:Strychnine / Q000037:antagonists & inhibitors; D014268:Trifluoperazine / Q000138:chemical synthesis / Q000494:pharmacology
D014150:Antipsychotic Agents; D006845:Hydrocarbons, Fluorinated; D014268:Trifluoperazine; D012110:Reserpine; D013331:Strychnine; D010433:Pentylenetetrazole